Gerald Wertheim

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

David T. Teachey, Simon F. Lacey, Pamela A. Shaw et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

Pharmacy, Immunology, Oncology +17

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Vijay Bhoj, Dimitrios C. Arhontoulis, Gerald Wertheim et al. · Blood · 2016 · 271 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Stephan Kadauke, Regina M. Myers, Yimei Li et al. · Journal of Clinical Oncology · 2021 · 212 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology

Edward J. Gunther, George K. Belka, Gerald Wertheim et al. · The FASEB Journal · 2002 · 204 citations

Life Sciences, Developmental Biology, Genetics +15

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Vinodh Pillai, Kavitha Muralidharan, Wenzhao Meng et al. · Blood Advances · 2019 · 202 citations · Full text

Medicine, Hematology, Oncology +16